Research & Clinical Trials > Featured Research

Click on the “Search Now” button to search for research studies enrolling people like you. Need help getting started? Click on “Tips for Searching Studies” to find resources and assistance to help you find studies.

ATR Inhibitor Plus Niraparib Study in Advanced Solid Tumors and Ovarian Cancer

ATR Inhibitor Plus Niraparib Study in Advanced Solid Tumors and Ovarian Cancer

Clinicaltrials.gov identifier:
NCT04267939

Treatment:

Ovarian, Breast, Pancreatic

Treatment with ATR Inhibitor for Advanced or Metastatic Solid Tumors

Treatment with ATR Inhibitor for Advanced or Metastatic Solid Tumors

Clinicaltrials.gov identifier:
NCT04657068

Treatment:

Breast, Ovarian, Pancreatic, Prostate

Nivolumab and Relatlimab in Advanced MSI-H Cancers Resistant to Prior PD-(L)1 Inhibitor

Nivolumab and Relatlimab in Advanced MSI-H Cancers Resistant to Prior PD-(L)1 Inhibitor

Clinicaltrials.gov identifier:
NCT03607890

Treatment:

Colorectal, Endometrial, Pancreatic

Men at High Genetic Risk for Prostate Cancer

Men at High Genetic Risk for Prostate Cancer

Clinicaltrials.gov identifier:
NCT03805919

Prevention:

Prostate

Blood Markers of Early Pancreas Cancer

Blood Markers of Early Pancreas Cancer

Clinicaltrials.gov identifier:
NCT03568630

Prevention:

Pancreatic

AMPLIFY: a new online weight loss study specifically for cancer survivors!

AMPLIFY: a new online weight loss study specifically for cancer survivors!

Clinicaltrials.gov identifier:
NCT04000880

Quality of Life:

Breast Cancer Survivor, Colorectal Cancer Survivor, Endometrial Cancer Survivor, Ovarian Cancer Survivor, Prostate Cancer Survivor

Developing a Test for the Detection of Ovarian Cancer

Developing a Test for the Detection of Ovarian Cancer

Clinicaltrials.gov identifier:
NCT04794322

Prevention:

Ovarian

Using TAS-117 to Treat Advanced Solid Tumors with Inherited PTEN Mutations

Using TAS-117 to Treat Advanced Solid Tumors with Inherited PTEN Mutations

Clinicaltrials.gov identifier:
NCT04770246

Treatment:

Breast, Colorectal, Endometrial

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Clinicaltrials.gov identifier:
NCT03581357

Quality of Life:

Breast Cancer Survivor, Colorectal Cancer Survivor, Endometrial Cancer Survivor, Ovarian Cancer Survivor, Prostate Cancer Survivor, Pancreatic Cancer Survivor

Mobile Mindfulness Meditation Intervention for Cancer Survivors

Mobile Mindfulness Meditation Intervention for Cancer Survivors

Clinicaltrials.gov identifier:
NCT03581357

Quality of Life:

Breast Cancer Survivor, Colorectal Cancer Survivor, Endometrial Cancer Survivor, Ovarian Cancer Survivor, Prostate Cancer Survivor, Pancreatic Cancer Survivor

Blood Tests to Measure Ovarian Reserves in Women with a BRCA Mutation or Women Treated for Early-Stage Breast Cancer

Blood Tests to Measure Ovarian Reserves in Women with a BRCA Mutation or Women Treated for Early-Stage Breast Cancer

Clinicaltrials.gov identifier:
NCT0823654

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor

A Study of Nivolumab in Selected Uterine Cancer Patients

A Study of Nivolumab in Selected Uterine Cancer Patients

Clinicaltrials.gov identifier:
NCT03241745

Treatment:

Endometrial

Genetic Education for Men (GEM Study)

Genetic Education for Men (GEM Study)

Clinicaltrials.gov identifier:
NCT02957981

Prevention:

Prostate

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Clinicaltrials.gov identifier:
NCT03327103

Treatment:

Prostate

Quality of Life:

Prostate Cancer Survivor

Pancreatic Cancer Screening Study for High Risk People

Pancreatic Cancer Screening Study for High Risk People

Clinicaltrials.gov identifier:
NCT03250078

Prevention:

Pancreatic

Study of Safety and Effectiveness of Motiva® Breast Implants

Study of Safety and Effectiveness of Motiva® Breast Implants

Clinicaltrials.gov identifier:
NCT03579901

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor

Study for People with Unexpected Genetic Results

Study for People with Unexpected Genetic Results

Clinicaltrials.gov identifier:
NCT02595957

Prevention:

Breast, Ovarian, Pancreatic, Prostate

A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes

A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes

Clinicaltrials.gov identifier:
NCT04171700

Treatment:

Breast, Ovarian, Pancreatic, Prostate, Endometrial

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Clinicaltrials.gov identifier:
NCT03572374

Quality of Life:

Breast Cancer Survivor

ELLIE's Project

ELLIE's Project

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor, Pancreatic Cancer Survivor, Melanoma Cancer Survivor

INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer

INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer

Clinicaltrials.gov identifier:
NCT02730338

Quality of Life:

Prostate Cancer Survivor

RADCOMP: A Study at the Heart of Breast Cancer Treatment

RADCOMP: A Study at the Heart of Breast Cancer Treatment

Clinicaltrials.gov identifier:
NCT02603341

Treatment:

Breast

IMPRES - Improving Memory after RRSO

IMPRES - Improving Memory after RRSO

Clinicaltrials.gov identifier:
NCT03187353

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor

Pancreatic Cancer Early Detection

Pancreatic Cancer Early Detection

Clinicaltrials.gov identifier:
NCT02206360

Prevention:

Pancreatic

WISDOM Study

WISDOM Study

Clinicaltrials.gov identifier:
NCT02620852

Prevention:

Breast

PROMPT

PROMPT

Clinicaltrials.gov identifier:
NCT02665195

Serum Folate in Patients Treated with Olaparib

Serum Folate in Patients Treated with Olaparib

Clinicaltrials.gov identifier:
NCT04024254

Treatment:

Breast, Ovarian

Talazoparib Beyond BRCA (TBB) Trial

Talazoparib Beyond BRCA (TBB) Trial

Clinicaltrials.gov identifier:
NCT02401347

Treatment:

Breast


Sponsored By:

Eisai